Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 11, 2021 - Ocular Therapeutix announced the FDA approval of Dextenza (dexamethasone ophthalmic insert), for the treatment of ocular itching associated with allergic conjunctivitis.
Return to publications